AMS:GLPG
Galapagos NV
- Stock
market
STOCKS
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD...Show More
Earnings
Earnings Release in 4 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus